Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14, 478

Detalles Bibliográficos
Autores principales: Panjideh, Hossein, Niesler, Nicole, Weng, Alexander, Fuchs, Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608844/
https://www.ncbi.nlm.nih.gov/pubmed/36287991
http://dx.doi.org/10.3390/toxins14100703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608844/
https://www.ncbi.nlm.nih.gov/pubmed/36287991
http://dx.doi.org/10.3390/toxins14100703

Ejemplares similares